Ciclopirox Olamine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 45802-400
  • Package NDC 45802-400-46
  • Package NDC 45802-400-49
  • Application number ANDA077676
  • SPL ID 372d6df9-d395-4ee2-9d16-9f21399f8604
  • SPL set ID eadbd29d-5990-4987-833f-40cd0b2d2868
  • UNII 50MD4SB4AP
  • RxCUI 309290

What the source publishes

Labeler
Padagis Israel Pharmaceuticals Ltd
Active ingredients
Ciclopirox Olamine
Form
SUSPENSION
Routes
TOPICAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:45802-400_372d6df9-d395-4ee2-9d16-9f21399f8604
{
  "name": "Ciclopirox Olamine",
  "splId": "372d6df9-d395-4ee2-9d16-9f21399f8604",
  "labels": [
    {
      "setId": "eadbd29d-5990-4987-833f-40cd0b2d2868",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eadbd29d-5990-4987-833f-40cd0b2d2868",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eadbd29d-5990-4987-833f-40cd0b2d2868"
    }
  ],
  "routes": [
    "TOPICAL"
  ],
  "labeler": "Padagis Israel Pharmaceuticals Ltd",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BOTTLE in 1 CARTON (45802-400-46)  / 60 mL in 1 BOTTLE",
      "package_ndc": "45802-400-46",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20061229"
    },
    {
      "sample": false,
      "description": "1 BOTTLE in 1 CARTON (45802-400-49)  / 30 mL in 1 BOTTLE",
      "package_ndc": "45802-400-49",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20061229"
    }
  ],
  "productId": "45802-400_372d6df9-d395-4ee2-9d16-9f21399f8604",
  "useDomain": "unknown",
  "dosageForm": "SUSPENSION",
  "productNdc": "45802-400",
  "deaSchedule": null,
  "genericName": "Ciclopirox Olamine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CICLOPIROX OLAMINE",
      "strength": "7.7 mg/mL"
    }
  ],
  "applicationNumber": "ANDA077676",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20061229",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "50MD4SB4AP"
    ],
    "rxcui": [
      "309290"
    ],
    "spl_set_id": [
      "eadbd29d-5990-4987-833f-40cd0b2d2868"
    ],
    "manufacturer_name": [
      "Padagis Israel Pharmaceuticals Ltd"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:45802-400_372d6df9-d395-4ee2-9d16-9f21399f8604"